A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART

A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART

Bibliographic Details
Main Authors: Gómez, Carmen Elena, Perdiguero, Beatriz, García-Arriaza, Juan, Cepeda, Victoria, Sánchez-Sorzano, Carlos Óscar, Mothe, Beatriz, Jiménez, José Luis, Muñoz-Fernández, María Ángeles, Gatell, Jose M., López Bernaldo de Quirós, Juan Carlos, Brander, Christian, García, Felipe, Esteban, Mariano
Format: Online
Language:English
Published: Public Library of Science 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636254/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636254/

Similar Items